CG Oncology Alternatives & Competitors
12 companies similar to CG Oncology — Attacking Bladder Cancer for a Better Tomorrow
Companies similar to CG Oncology
Y-mAbs Therapeutics, Inc.
Innovative pediatric immunotherapies for Real-life Possibilities
New York, United States
Teon Therapeutics Inc.
Teon is a clinical company targeting metabolic signaling pathways and pioneering the devel...
Redwood City, United Stat...
Apexigen
Creating Transformative Immunotherapies for Patients with Cancer
San Carlos, United States
Track all CG Oncology competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
GenVivo, Inc.
We are a clinical stage company with an off-the-shelf, vector-based platform, for immunoth...
San Marino, United States
Circio Holding ASA
Developing novel circular RNA and immunotherapy medicines.
Oslo, Norway
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Waltham, United States
Sensei Bio
We follow the immune system’s teachings to discover new treatments that inspire the body t...
Rockville, United States
Lytix Biopharma
A clinical-stage immuno-oncology company developing proprietary oncolytic drugs as a novel...
Oslo, Norway
Enterome
Delivering the promise of immunotherapy
Paris, France
NEOGAP Therapeutics AB
Science for cure.
Stockholm, Sweden
About CG Oncology
CG Oncology is a late-stage clinical biopharmaceutical company, founded in 2010, focusing on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is in a Phase 3 trial for the treatment of BCG-unre...
Oncolytic Immunotherapy, Bladder Cancer, Clinical-Stage Biopharmaceutical, CG0070, Immunotherapies, BioSante Pharmaceuticals, NMIBC, Phase 3 Trial, Keytruda, Opdivo, Urologic Cancer, Clinical Trial, Biopharmaceutical Company, Immunotherapy Agent, Patient Therapies
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches CG Oncology and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at CG Oncology on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
